Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
US9382312B2 · kind B2 · utility
0Cited by
6References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2013 |
| Grant date | Jul 5, 2016 |
| Priority date | — |
| Expiry date | Mar 15, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2015/8518
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide, and to the use of said antibodies in the field of Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.